AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclose herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company. Aarti Drugs Ltd - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclose herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2021 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company. Aarti Drugs Ltd - 524348 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Rushikesh DeoleDesignation :- Company Secretary and Compliance Officer Aarti Drugs Ltd - 524348 - Closure of Trading Window
This is to inform that the Trading Window of the Company will remain closed from Thursday, July 1, 2021 until the expiry of 48 hours after the declaration of Financial Results of the Company for the quarter ended June 30, 2021. Aarti Drugs Ltd - 524348 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith the Annual Secretarial Compliance Report of the Company issued by M/s. Sunil M. Dedhia & Co., Company Secretaries in Practice, for the financial year ended March 31, 2021. AARTI DRUGS LTD. - 524348 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith the Annual Secretarial Compliance Report of the Company issued by M/s. Sunil M. Dedhia & Co., Company Secretaries in Practice, for the financial year ended March 31, 2021. AARTI DRUGS LTD. - 524348 - Revised Compliance Of Regulation 40(10) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended September 30, 2020
We are forwarding herewith Revised Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from Jagdish Patel & Co., Practicing Company Secretary, for the half year ended September 30, 2020 for your perusal and record. AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below. Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has issued Duplicate share certificates in lieu of original share certificates AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below.